PAX5 and acute lymphoblastic leukemia: PAX5 alterations also include intragenic amplifications (PAX5AMP) and germline mutations. The incidence PAX5-ITD is around 0.5–1.4% in B-ALL and consist in an approximately 4–5 copies in PAX5 exons 2 to 5.